Helys Group

Active Risk: not assessed Private limited companyfounded 2024active for 2 yearsPluim 20, 8550 ZwevegemKBO/BCE: BE 1012.807.682

Helys Group

Follow Report Compare

Holdings

own 2025 accounts, the bar shows equity in euros

This companyHelys Group3 holdings, 2 countries 2025 accounts

Belgium 2 Year Equity Result

BE SOPACHEM BE 2025€426,554 result €407,699 (2025)
BE AXIL BIO 2025€139,580 result €7,603 (2025)

Europe 1 Year Equity Result

NL SOPACHEM NL 2024€161,220 result €25,449 (2024)

Source: list of holdings in its own 2025 accounts. Holdings that file themselves stand with their latest accounts, the others with the amounts of that list, in their own currency.

Holdings and subsidiaries

3 holdings

Share, source and own figures per holding (3)

Source for every holding own accounts 2025

Axil Biosubsidiary
Equity €139,580 Profit of €7,603 in 2025 (profit of €7,747 in 2024) Checked score 88

100%
SOPACHEMsubsidiary
Equity €426,554 Profit of €407,699 in 2025 (profit of €213,068 in 2024) Checked score 81

100%
SOPACHEM NLNLsubsidiary
Equity €161,220Result €25,449

100%

Holdings through the years 2024 to 2025

Holdings through the years
Name	2024	2025
Axil Bio 2024 to 2025: 100%	100%
SOPACHEM 2024 to 2025: 100%	100%
SOPACHEM NLNL 2024 to 2025: 100%	100%

Source: list of holdings in its own accounts

Board mandates elsewhere

1 board mandate

Board mandates of Helys GroupHelys Group sits on their board1

SOPACHEM

Director · 2 locations

Founded in 1970 · 3.8 FTE (2025)

Connections & network

2 current directors

Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet